Related Experiment Video
Updated: Jan 9, 2026

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
Published on: May 10, 2024
A nucleotide regulates NR4A1 status in gastric cancer
Qi-Xiang Ma1, Miao Yin1, Qun-Ying Lei2
1Fudan University Shanghai Cancer Center & Institutes of Biomedical Sciences & School of Basic Medical Sciences; Cancer Institutes, Key Laboratory of Breast Cancer in Shanghai; Shanghai Key Laboratory of Radiation Oncology; The Shanghai Key Laboratory of Medical Epigenetics, National Key Laboratory of Brain Function and Diseases, Shanghai Medical College, Fudan University, Shanghai, China.
Abstract:
How the oncogenic and tumor-suppressor roles of orphan nuclear receptor 4A1 (NR4A1) are balanced remains unclear. In this issue of Molecular Cell, Cai et al.1 report that a pyrimidine metabolite-UMP-acts as an endogenous regulator of NR4A1 by directly binding to abrogate its suppressive effect on gastric cancer development.
Insights
Pyrimidine metabolite uridine monophosphate (UMP) regulates the nuclear receptor 4A1 (NR4A1). UMP binding prevents NR4A1 from suppressing gastric cancer, revealing a new therapeutic target.
Area of Science:
- Molecular biology
- Cancer research
- Nuclear receptor signaling
Background:
- The dual role of orphan nuclear receptor 4A1 (NR4A1) as both an oncogene and tumor suppressor is not fully understood.
- Understanding the regulation of NR4A1 is crucial for developing targeted cancer therapies.
Purpose of the Study:
- To investigate the endogenous regulatory mechanisms of NR4A1.
- To elucidate how NR4A1's tumor-suppressive function is modulated in gastric cancer.
Main Methods:
- Biochemical assays to confirm direct binding of UMP to NR4A1.
- Cellular experiments to assess the impact of UMP on NR4A1 activity and gastric cancer cell proliferation.
- Analysis of NR4A1 expression and UMP levels in gastric cancer tissues.
Main Results:
- Uridine monophosphate (UMP), a pyrimidine metabolite, directly binds to NR4A1.
- UMP binding abrogates the suppressive effect of NR4A1 on gastric cancer development.
- This interaction reveals a novel mechanism controlling NR4A1's function in cancer.
Conclusions:
- UMP acts as a key endogenous regulator of NR4A1, shifting its role in gastric cancer.
- Targeting the NR4A1-UMP interaction could offer a new therapeutic strategy for gastric cancer.
- Further research into metabolite-mediated regulation of nuclear receptors is warranted.
Related Concept Videos
Transducer Mechanism: Nuclear Receptors
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
The Nucleolus
Regulation of Nuclear Protein Sorting
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

